BioVie Inc.BIVINASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank69
3Y CAGR-26.3%
5Y CAGR-33.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-26.3%/yr
vs +106.1%/yr prior
5Y CAGR
-33.4%/yr
Recent acceleration
Acceleration
-132.5pp
Decelerating
Percentile
P69
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $18.03M | +1.1% |
| 2025 | $17.84M | -44.6% |
| 2024 | $32.18M | -28.6% |
| 2023 | $45.08M | +65.4% |
| 2022 | $27.25M | -80.3% |
| 2021 | $138.05M | +5026.6% |
| 2020 | $2.69M | +7.9% |
| 2019 | $2.50M | +5.2% |
| 2018 | $2.37M | +52.7% |
| 2017 | $1.55M | - |